i-SENS Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
16,292
27,345
29,175
27,708
28,010
Total Accounts Receivable
21,897
26,940
24,789
34,393
37,682
Inventories
21,711
21,122
21,053
31,595
29,094
Other Current Assets
2,198
2,099
3,519
1,192
992
Total Current Assets
62,097
77,505
78,536
94,888
95,778
Net Property, Plant & Equipment
75,307
64,658
72,304
80,629
98,697
Total Investments and Advances
5
17,564
22,007
10,821
9,168
Long-Term Note Receivable
157
83
1,035
1,034
1,513
Intangible Assets
3,723
3,536
1,677
21,310
19,320
Other Assets
1,106
927
4,883
4,281
7,029
Total Assets
144,221
166,503
183,238
215,066
234,077
ST Debt & Current Portion LT Debt
1,404
870
2,727
12,214
4,150
Accounts Payable
4,049
4,160
4,467
5,430
7,082
Income Tax Payable
3,711
2,334
3,435
4,102
2,648
Other Current Liabilities
4,398
6,030
7,565
10,440
11,900
Total Current Liabilities
13,561
13,394
18,194
32,186
25,780
Long-Term Debt
21,420
27,935
25,319
23,007
37,876
Provision for Risks & Charges
802
2,177
2,914
3,324
3,134
Deferred Taxes
1,661
1,257
634
1,732
2,305
Other Liabilities
632
702
1,159
3,947
1,870
Total Liabilities
39,902
47,695
51,015
62,835
68,925
Common Equity (Total)
103,129
117,610
132,022
149,672
162,796
Total Shareholders' Equity
103,129
117,610
132,022
149,672
162,796
Total Equity
104,319
118,808
132,222
152,231
165,152
Liabilities & Shareholders' Equity
144,221
166,503
183,238
215,066
234,077
Accumulated Minority Interest
1,190
1,199
200
2,558
2,356

About i-SENS

View Profile
Address
I Sens Building
Seoul SL 06646
Korea, Republic Of
Employees -
Website http://www.i-sens.co.kr
Updated 09/14/2018
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. Its products include bolld glucose monitoring devices, electrolyte analyzers and cartridges, blood coagulation measuring instrument, connectors, and others. The company was founded by Cha Geun-Sig and Nam Hak-Hyun on May 4, 2000 and is headquartered in Seoul, South Korea.